Avelumab in newly diagnosed glioblastoma multiforme: The SEJ study.

e13571Background: Glioblastoma Multiforme (GBM) has well documented systemic and local immunosuppressive mechanisms to escape immune surveillance and grow. GBM tumor cells as well as the microglia ...